IAG Wealth Partners’s Quest Diagnostics DGX Stock Holding History

IAG Wealth Partners’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$932	Hold	4	–	–	﹤0.01%	506
2026 Q2	$848	Hold	4	–	–	﹤0.01%	489
2026 Q1	$784	Hold	4	–	–	﹤0.01%	490
2025 Q4	$694	Hold	4	–	–	﹤0.01%	475
2025 Q3	$762	Hold	4	–	–	﹤0.01%	490
2025 Q2	$719	Hold	4	–	–	﹤0.01%	465
2025 Q1	$677	Hold	4	–	–	﹤0.01%	478
2024 Q4	$603	Hold	4	–	–	﹤0.01%	490
2024 Q3	$621	Buy	+4	New	+$597	﹤0.01%	473

Other funds holding DGX

Boston Partners Boston, Massachusetts $111B AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Davis Selected Advisers Tucson, Arizona $23.2B AUM 18.42% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return

M&G plc London, United Kingdom $19.9B AUM 15.09% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

IAG Wealth Partners's DGX Position: Q3 2026 in Review

IAG Wealth Partners held its Quest Diagnostics (DGX) position steady in Q3 2026 at 4 shares worth $932. The position accounts for ﹤0.01% of the portfolio, ranked #506.

IAG Wealth Partners first reported a position in DGX in Q3 2024 and has held it in 9 quarters since. 722 funds tracked by Wall St. Rank hold DGX as of Q3 2026.

IAG Wealth Partners held 4 shares of Quest Diagnostics worth $932 as of Q3 2026.
IAG Wealth Partners left its Quest Diagnostics share count unchanged in Q3 2026.
Quest Diagnostics made up ﹤0.01% of IAG Wealth Partners's portfolio in Q3 2026, its #506 holding.
IAG Wealth Partners first reported a position in Quest Diagnostics in Q3 2024 and has held it in 9 quarters since.
722 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.

Based on IAG Wealth Partners's 13F filing for Q3 2026, filed 6 Nov 2026.